AHA Scientific Sessions 2025 Abstract
Low-Cost Promotional Coronary Artery Calcium Screening Identifies High-Risk Patients Missed by Traditional Referral Pathways in Urban Hospital
Cohort study of 1,743 peopleBiomarkers
Papers on statin + ezetimibe
188 papers59 new in 30 days
Monday, November 3
AHA Scientific Sessions 2025 Abstract
Real-World Assessment of the Efficacy of Inclisiran in Lowering Low-Density Lipoprotein Cholesterol: Outcomes From AAH Tertiary Cardiovascular Clinics
Cohort study of 380 peopleInclisiran
AHA Scientific Sessions 2025 Abstract
The Role of Early Ezetimibe Combination with Atorvastatin in Patients with Atherosclerotic Cardiovascular Disease
Randomized trial in 137 peopleAtherosclerotic cardiovascular disease
AHA Scientific Sessions 2025 Abstract
Assessment of Lipid-Lowering Therapy and Atherosclerotic Cardiovascular Disease Outcomes in Patients with Familial Hypercholesterolemia: Insights from the NIH All Of Us Dataset
Cohort study of 287,012 peopleFamilial hypercholesterolemia
AHA Scientific Sessions 2025 Abstract
Lipid lowering effects of inclisiran in statin- or PCSK9i monoclonal antibody-intolerant patients
Cohort study of 62 peopleInclisiran
Thursday, October 23
ENDO 2025 Abstract
SAT-263 Access to Bempedoic Acid - A Real World Assessment in an Academic Clinical Practice
Cohort study of 72 peopleBempedoic acid
ENDO 2025 Abstract
SUN-661 Impact of GLP-1 Analogs vs. Lipid Lowering Agents on Risk for Acute Pancreatitis in Hypertriglyceridemia: A TriNetX Analysis
Cohort study of 296,961 peopleAcute pancreatitis
Monday, July 21
Wednesday, July 16
Friday, June 13
ADA Scientific Sessions 2025 Abstract
Combination Lipid-Lowering Therapy and the Risks of Various Types of Cancers in Patients with Type 2 Diabetes
Cohort study of 89,866 peopleCancer
Thursday, May 15
Cardiology Research
Lipid-Lowering Therapy in Post-Acute Coronary Syndrome Patients: An Observational Study
Cohort study of 122 peopleAcute coronary syndrome
Monday, January 6
Expert Opinion on Drug Safety
Autoimmune hepatitis associated with statins: a retrospective study of pharmacovigilance databases and review of the literature
Computational studyPopulations
Sunday, December 22
Journal of Internal Medicine
Safety and efficacy of moderate-intensity statin with ezetimibe in elderly patients with atherosclerotic cardiovascular disease
Randomized trial in 561 peopleStatins
Wednesday, November 13
Journal of Clinical Medicine
A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in Hungary
Cohort study of 12,997 peopleAcute coronary syndrome
Tuesday, September 10
Journal of Cachexia, Sarcopenia and Muscle
Novel insights into the association between genetically proxied inhibition of proprotein convertase subtilisin/kexin type 9 and risk of sarcopenia
Mendelian randomization in peopleMuscle
Friday, July 5
Frontiers in Pharmacology
Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region
Cohort study of 369 peopleIschemic heart disease
Tuesday, June 25
American Journal of Preventive Cardiology
Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond
ReviewInterventions
Monday, April 29
Circulation Cardiovascular Quality and Outcomes
Association of Use and Dose of Lipid-Lowering Therapy Post Acute Myocardial Infarction With 5-Year Survival in Older Adults
Cohort study of 2,258 peopleST-elevation myocardial infarction
Monday, April 8
Frontiers in Endocrinology
Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial
Randomized trial in 149 peopleRosuvastatin
Thursday, February 8
PLOS One
Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis
Meta-analysis of randomized trialsCardiovascular disease
Sunday, February 4
Monday, December 18
Journal of the American Heart Association
Unraveling Potential Sex-Specific Effects of Cardiovascular Medications on Longevity Using Mendelian Randomization
Mendelian randomization in 415,311 peopleInterventions
Friday, September 29
Wednesday, April 19
Thursday, April 6
Journal of the American College of Cardiology
Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis
Randomized trial in 3,780 peopleStatin + ezetimibe
Monday, March 20
Tuesday, December 13
Frontiers in Pharmacology
Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS
Study in peoplePCSK9 inhibitors